Opportunistic Infections Put a Damper on Belatacept After Lung Transplant
HONOLULU — Lung transplant clinicians had a rocky start using belatacept (Nulojix) for immunosuppression at one large-volume center, though they maintained that the agent could still be used to preserve renal function without affecting the patient’s graft. Out of 388 lung transplant recipients from 2019 to 2022, there were 37 who did not tolerate nephrotoxic […]
Sotagliflozin Gets FDA’s Blessing for Heart Failure
After a rocky development and regulatory road, the FDA has approved sotagliflozin (Inpefa) for treating heart failure in patients with or without diabetes, manufacturer Lexicon Pharmaceuticals announced on Friday. The dual SGLT1 and SGLT2 inhibitor is indicated for reducing the risk of cardiovascular death and urgent visits or hospitalization for heart failure in adults with […]